Category: Uncategorized

Welcome Dr. Farhad Safi

Central Florida would like to Welcome Dr. Farhad Safi, MD, Lieutenant Colonel of the US Army Medical Corps, on joining our group of retina specialist. Dr.Farhad Safi is a board-certified ophthalmologist and surgeon who specializes in the diseases of the retina, choroid, and vitreous. He is currently serving as Lieutenant Colonel in the U.S. Army, […]

Read More

Living with Vision Loss Due to Neovascular (wet) Age-Related Macular Degeneration (AMD)?

We are looking for people to take part in a clinical research study to help us learn more about an investigational medication for Neovascular (web) age-related macular degeneration (AMD). The investigational medication has been designed to work differently from currently available treatments. We are trying to find out if the investigational medication may result in […]

Read More

Diagnosed with Diabetic Retinopathy? Help Advance Research.

Diabetic Retinopathy? Help advanced research on how to treat early diabetic retinopathy What Is The Study About? The study is being done to find out more information on whether a pill taken daily by mouth can slow or prevent the worsening of diabetic retinopathy Who Can Participate? Adults age 18 to 80 with diabetic retinopathy. […]

Read More

A Message from Dr. Suzanne M. Demming

A Message from CFR Partner Dr. Suzanne M. Demming: “After 30 wonderful years, I have decided to retire and close out my time at Central Florida Retina this April, 2021. I hope you have had a satisfying and pleasant experience while in my care. Thank you for trusting me with your eye care and for […]

Read More

Now in Oviedo 3 Days a Week!

Central Florida Retina is now available to patients visiting our Oviedo office three days per week! Dr. Kumar and Dr. Feinstein will be available to see patients on Tuesdays, Wednesdays, and Fridays, treating those in need of retinal care in the greater Oviedo area. Visit our Oviedo location page to learn more about our services […]

Read More

Panorama Study For Patients With Diabetic Retinopathy

Clinical Trial for Patients with NPDR Dear Respected Colleague, We are pleased to inform you that CFR is participating as a recruiting study site in the Regeneron Pharmaceuticals, Inc. PANORAMA study: a phase 3 study of the efficacy and safety of intravitreal (IVT) aflibercept in patients with moderately severe to severe NPDR. Approximately 360 patients […]

Read More
Partner Logos
WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.